Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
NCT01379287
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Iso-Fludelone
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]
[object Object]